Search results
1 sty 2019 · The World Health Organization (WHO) has developed Guidelines for the pharmacologic and radiotherapeutic management of cancer pain in adults and adolescents to provide evidence-based guidance to initiating and managing cancer pain.
- Guidelines for the management of cancer pain
Between 30% and 50% of cancer deaths could be prevented by...
- Guidelines for the management of cancer pain
Between 30% and 50% of cancer deaths could be prevented by modifying or avoiding key risk factors and implementing existing evidence-based prevention strategies. The cancer burden can also be reduced through early detection of cancer and management of patients who develop cancer.
The World Health Organization (WHO) Guidelines for the pharmacologic and radiotherapeutic management of cancer pain in adults and adolescents are intended to provide evidence-based guidance to health-care providers on appropriate approaches to initiating and managing cancer pain in adolescents and adults, including older persons.
5 Cancer Pain Management – Guiding Principles. The GDG and stakeholders who developed the guidelines determined that all recommendations arising from the meeting would be underpinned by the following overarching principles of effective health systems and best clinical practice: Go to: 5.1.
Aim and scope. The WHO Report on Cancer: setting priorities, investing wisely and providing care for all provides evidence-based public health- and policy-oriented guidance on cancer, based on the latest available evidence and international experience. The report catalyses global collaboration and provides guidance on next steps to improve cancer control in countries.
16 maj 2010 · Fact Sheets / Cancer treatment. 16 May 2010. A national cancer control programme should establish guidelines for integrating treatment resources with programmes for screening, early diagnosis, and palliative care, and provide therapeutic standards for the most important cancers in the country.
The information in this resource helps to provide guidance to health care providers (i.e. the end-users of these guidelines: physicians, nurses, pharmacists and caregivers) on the adequate relief of pain associated with cancer.
